John A. Kollins
Sr. VP, Chief Business Officer, Oncotelic Therapeutics, Inc.
Companies
- Satsuma Pharmaceuticals, Inc.Board member Sep 12, 2019 to Jun 8, 20231
- Satsuma Pharmaceuticals, Inc.Chief executive officer Sep 12, 2019 to Jun 8, 20231
- Satsuma Pharmaceuticals, Inc.President Sep 12, 2019 to Jun 8, 20231
- Paratek Pharmaceuticals, Inc.SVP, Chief Business Officer Jun 4, 2012 to Oct 30, 20142
- Oncotelic Therapeutics, Inc.Board member Dec 18, 2008 to Jan 22, 20093
- Oncotelic Therapeutics, Inc.Chief executive officer Dec 18, 2008 to Jan 22, 20093
- Oncotelic Therapeutics, Inc.Sr. VP, Chief Business Officer Mar 5, 2007 to May 1, 20074
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Satsuma Pharmaceuticals, Inc.0 shares5Jun 6, 2023
As of each latest filing. The line shows shares held over time.
Recent filings
- Jun 6, 2023U 305,911 shares at $0.91 of Satsuma Pharmaceuticals, Inc.5
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5